synthetic oligonucleotides
Current RNA-seq methods that use cDNA conversion are missing important information in SARS-CoV-2 genomes and other significant RNA molecules, researchers say.
Twist Bioscience Fiscal Q3 Revenues Grow 65 Percent
Twist said that healthcare is now the largest end market for its oligonucleotide products, representing nearly 50 percent of all revenues.
The new cell hashing- and combinatorial indexing-based method helps map true single-cell whole transcriptome data to spatial location.
Codex DNA Closes $122.7M IPO
The San Diego-based synthetic nucleic acids company, formerly known as SGI-DNA, sold approximately 7.7 million shares at an offering price of $16 per share.
Molecular Assemblies Extends Series A Financing Round by $11.8M
The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund.
Mar 18, 2021
Feb 5, 2021
Dec 2, 2020
Twist Bioscience Proposes $250M Public Offering
Nov 23, 2020
Nov 23, 2020
Twist Bioscience Fiscal Q4 Revenues More Than Double
Aug 6, 2020
Twist Bioscience Q3 Revenues Grow 56 Percent
Jun 4, 2020
Twist Bioscience Prices $100M Stock Offering
May 7, 2020
Twist Bioscience Q2 Revenues Increase 42 Percent
Mar 2, 2020